Yahoo
Frankfurt - Delayed Quote EUR

Stryker Corporation (SYK.F)

292.60 -8.70 (-2.89%)
At close: November 6 at 6:26:11 PM GMT+1
Chart Range Bar
Loading chart for SYK.F
  • Previous Close 301.30
  • Open 295.10
  • Bid 290.70 x 50000
  • Ask 291.30 x 50000
  • Day's Range 291.20 - 295.10
  • 52 Week Range 230.90 - 332.80
  • Volume 118
  • Avg. Volume 245
  • Market Cap (intraday) 111.39B
  • Beta (5Y Monthly) 0.77
  • PE Ratio (TTM) 36.21
  • EPS (TTM) 8.08
  • Earnings Date (est.) Jan 28, 2027
  • Forward Dividend & Yield 3.15 (1.08%)
  • Ex-Dividend Date Sep 30, 2026
  • 1y Target Est --

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

www.stryker.com

56,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SYK.F
1.06%
S&P 500 (^GSPC)
7.76%

1-Year Return

SYK.F
3.07%
S&P 500 (^GSPC)
9.77%

3-Year Return

SYK.F
16.28%
S&P 500 (^GSPC)
68.96%

5-Year Return

SYK.F
29.92%
S&P 500 (^GSPC)
57.04%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 6.52B
Earnings 753M
Profit Margin 11.55%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
2B
4B
6B
12.0%
14.0%
16.0%
18.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    13.78%

  • Return on Assets (ttm)

    8.35%

  • Return on Equity (ttm)

    16.02%

  • Revenue (ttm)

    26.3B

  • Net Income Avi to Common (ttm)

    3.62B

  • Diluted EPS (ttm)

    8.08

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.27B

  • Total Debt/Equity (mrq)

    65.79%

  • Levered Free Cash Flow (ttm)

    3.7B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: